BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,690 | -3.9% | 126,014 | -4.5% | 0.03% | -3.2% |
| Q2 2023 | $14,247 | -16.3% | 132,007 | -3.4% | 0.03% | -20.5% |
| Q1 2023 | $17,022 | -24.3% | 136,646 | -8.7% | 0.04% | -32.8% |
| Q4 2022 | $22,484 | -99.9% | 149,676 | +20.7% | 0.06% | +16.0% |
| Q3 2022 | $16,720,000 | -17.0% | 123,961 | -8.2% | 0.05% | -5.7% |
| Q2 2022 | $20,143,000 | -17.5% | 135,098 | -5.6% | 0.05% | +6.0% |
| Q1 2022 | $24,412,000 | +3.3% | 143,127 | +56.1% | 0.05% | -9.1% |
| Q4 2021 | $23,637,000 | -1.5% | 91,690 | +4.3% | 0.06% | -8.3% |
| Q3 2021 | $23,987,000 | +2.6% | 87,870 | -15.8% | 0.06% | +9.1% |
| Q2 2021 | $23,374,000 | +62.6% | 104,403 | -20.7% | 0.06% | +41.0% |
| Q1 2021 | $14,379,000 | +12.7% | 131,691 | -15.8% | 0.04% | +5.4% |
| Q4 2020 | $12,754,000 | -17.4% | 156,454 | -29.8% | 0.04% | +48.0% |
| Q3 2020 | $15,434,000 | – | 222,936 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |